Back
Swisscom AG Vs. Keros Therapeutics Industry Stock Comparison
Buy
64
SCMWY
Swisscom AG
Last Price:
56.45
Seasonality Move:
0.28%
Sell
27
KROS
Keros Therapeutics
Last Price:
45.71
Seasonality Move:
4.22%
Buy
64
Swisscom AG (SCMWY)
is a Buy
Is Swisscom AG a Buy, Sell or Hold?
- The current Swisscom AG [SCMWY] share price is $56.45. The Score for SCMWY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- SCMWY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCMWY Stock Price Chart
What is Swisscom AG's stock price today?
-
The Swisscom AG share price today is $56.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCMWY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
SCMWY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.21 | Buy |
Relative Strength Index (14 RSI): | 55.92 | Buy |
Chaikin Money Flow: | 9265 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.55 - 56.57) | Buy |
Bollinger Bands (100): | (55.01 - 58.67) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.79 | Sell |
Relative Strength Index (14 RSI): | 38.41 | Sell |
Chaikin Money Flow: | 239305 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.72 - 49.1) | Sell |
Bollinger Bands (100): | (49.87 - 64.91) | Sell |
SCMWY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.19 | Buy |
20-day SMA: | 55.99 | Buy |
50-day SMA: | 55.43 | Buy |
200-day SMA: | 58.03 | Sell |
8-day EMA: | 56.1 | Buy |
20-day EMA: | 55.86 | Buy |
50-day EMA: | 55.96 | Buy |
200-day EMA: | 57.76 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.61 | Buy |
20-day SMA: | 47.29 | Sell |
50-day SMA: | 51.65 | Sell |
200-day SMA: | 47.07 | Sell |
8-day EMA: | 45.93 | Sell |
20-day EMA: | 47.34 | Sell |
50-day EMA: | 50.89 | Sell |
200-day EMA: | 50 | Sell |
Swisscom AG Earnings Growth & SCMWY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and a decrease next year of $0.04 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Swisscom AG Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |